ENANTA PHARMACEUTICALS INC's ticker is ENTA and the CUSIP is 29251M106. A total of 123 filers reported holding ENANTA PHARMACEUTICALS INC in Q4 2014. The put-call ratio across all filers is 2.63 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $342,000 | +26.2% | 10,200 | 0.0% | 0.23% | +145.7% |
| Q3 2016 | $271,000 | +20.4% | 10,200 | 0.0% | 0.09% | +2.2% |
| Q2 2016 | $225,000 | -25.0% | 10,200 | 0.0% | 0.09% | -28.0% |
| Q1 2016 | $300,000 | -11.0% | 10,200 | 0.0% | 0.12% | +31.6% |
| Q4 2015 | $337,000 | -8.7% | 10,200 | 0.0% | 0.10% | +33.8% |
| Q3 2015 | $369,000 | -94.4% | 10,200 | -93.0% | 0.07% | -88.5% |
| Q2 2015 | $6,582,000 | +41.6% | 146,300 | -3.6% | 0.62% | +41.2% |
| Q1 2015 | $4,648,000 | -42.3% | 151,800 | -4.2% | 0.44% | -43.1% |
| Q4 2014 | $8,055,000 | +27.9% | 158,400 | -0.4% | 0.77% | +18.8% |
| Q3 2014 | $6,296,000 | -33.3% | 159,100 | -27.4% | 0.65% | -19.9% |
| Q2 2014 | $9,441,000 | +9.0% | 219,200 | +1.2% | 0.81% | +14.7% |
| Q1 2014 | $8,662,000 | +17.4% | 216,600 | -19.9% | 0.71% | +16.9% |
| Q4 2013 | $7,377,000 | +26.3% | 270,400 | +6.1% | 0.60% | +11.0% |
| Q3 2013 | $5,842,000 | +25.5% | 254,900 | -3.0% | 0.54% | +14.7% |
| Q2 2013 | $4,654,000 | – | 262,800 | – | 0.48% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Krensavage Asset Management, LLC | 862,848 | $42,556,000 | 14.73% |
| Fairmount Funds Management LLC | 171,147 | $8,441,000 | 3.56% |
| ARMISTICE CAPITAL, LLC | 1,648,000 | $81,279,000 | 1.87% |
| FARALLON CAPITAL MANAGEMENT LLC | 1,995,000 | $98,393,000 | 0.49% |
| Jackson Creek Investment Advisors LLC | 21,409 | $1,056,000 | 0.37% |
| Hennion & Walsh Asset Management, Inc. | 113,940 | $5,620,000 | 0.34% |
| Virtus ETF Advisers LLC | 14,721 | $726,000 | 0.31% |
| Granahan Investment Management | 193,416 | $9,539,000 | 0.20% |
| Yorktown Management & Research Co Inc | 4,500 | $222,000 | 0.18% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 242,257 | $11,948,000 | 0.09% |